Group 1 - The A-share medical sector continues to adjust, with leading stocks like WuXi AppTec, United Imaging Healthcare, and Aimeike all dropping over 1%, while Tigermed and Furuide fell more than 4% [1] - The largest medical ETF in A-shares (512170) dropped nearly 2%, reaching a three-month low and breaching the six-month moving average, indicating potential large capital inflows during the dip [1] - The medical sector's performance is currently diverging from its valuation, with the medical ETF (512170) trading at a PE ratio of 33.5 times, which is still below 65% of its historical range over the past decade [3][4] Group 2 - The medical device sector showed significant revenue growth of 10.65% year-on-year in Q3 2025, with expectations for continued positive trends into Q4 2025 [3] - The CXO (Contract Research Organization) segment performed strongly, with Q3 2025 revenue up 10.93% and net profit attributable to shareholders up 47.90%, indicating a favorable outlook for the industry [3] - The medical ETF (512170) has a current scale of over 25.8 billion yuan, making it the largest medical ETF in the market, focusing on "medical devices + medical services" [6][7]